Moreover, the immunoreactivity for p16INK4A was increased in the vessels from the diabetic mice as compared with the non-diabetic controls and the diabetes-induced increase in p16INK4A immunoreactivity was markedly blunted in the vessels from the diabetic mice that were treated with ABH. The gene discussed is CDKN2A; the disease is diabetes mellitus.